Hong Kong · Delayed Price · Currency is HKD WuXi Biologics Company Description
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.
It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (“TAA”) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh.
It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities.
WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.
| Country | Cayman Islands |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13,252 |
| CEO | Zhisheng Chen |
Contact Details
Address: No. 108, Meiliang Road Wuxi China | |
| Website | wuxibiologics.com |
Stock Details
| Ticker Symbol | 2269 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG970081173 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Jian Dong | Chief Executive Officer of WuXi Vaccines |
| Dr. Zhisheng Chen Ph.D. | Chief Executive Officer and Executive Director |
| Dr. Ge Li Ph.D. | Founder and Chairman |
| Dr. Jijie Gu Ph.D. | Chief Scientific Officer and President of Global Biologics Research |
| Lina Fan Ph.D. | Senior Vice President and Head of Investor Relations |
| He Wang | General Counsel, Chief Compliance Officer, SVice President and Head of Legal and Compliance Department |
| Li Xiong | Vice President and Head of Global Human Resources |
| Angus Scott Marshall Turner M.B.A. | Senior Vice President and Head of Global BD and Alliance Management |
| William Aitchison Ph.D. | Senior Vice President and Head of US Operations and Key Account Executive Advisor |
| Dr. Juergen Hinderer Ph.D. | Senior Vice President and Head of Global Engineering |